Adamis Pharmaceuticals Corp ADMP Income Statement

Adamis pharmaceuticals corp (ADMP)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
REVENUE, net
21,871	22,113	20,727	18,657	16,813	15,086	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	0	-	-	0	0	0	0	0	0
REVENUE, net
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
REVENUE, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF GOODS SOLD
-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF GOODS SOLD
15,540	15,478	14,319	12,631	11,360	9,797	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Gross Profit
6,330	6,635	6,407	6,026	5,452	5,288	5,234	4,998	5,396	5,653	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
23,320	25,287	26,898	28,133	27,495	25,948	25,215	24,428	23,720	22,819	21,568	21,155	20,083	17,127	14,361	11,151	8,830	9,007	9,382	8,601	7,349	5,891	4,466	3,884	3,389	2,601	2,367	2,034	2,008	1,813	2,078	2,555	2,649	2,648	2,769	2,958	3,365	0	0	0
RESEARCH AND DEVELOPMENT
10,216	10,375	16,161	16,751	18,741	18,793	14,575	11,915	8,265	7,526	5,315	5,562	7,806	9,697	9,360	9,048	6,888	4,843	5,015	4,430	4,900	3,924	2,924	2,522	1,006	973	971	1,197	1,209	1,643	1,618	1,771	2,165	2,152	4,063	3,506	2,875	0	0	0
IMPAIRMENT EXPENSE
0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS ON IMPAIRMENT OF FIXED ASSETS
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from Operations
-30,671	-29,350	-36,966	-38,868	-40,794	-39,463	-34,556	-31,441	-26,686	-24,789	-21,603	-22,382	-24,896	-25,204	-22,885	-19,618	-15,718	-13,850	-14,397	-13,031	-12,250	-9,816	-7,390	-6,406	-4,395	-3,575	-3,338	-3,232	-3,217	-3,456	-3,697	-4,327	-4,815	-4,800	-6,832	-6,464	-6,241	0	0	0
OTHER INCOME (EXPENSE)
Interest Expense
137	123	93	102	131	157	184	206	214	231	0	0	0	-	0	0	-	-	-	-	-	371	5,669	8,447	8,626	9,095	4,642	2,443	2,333	1,722	879	302	35	64	133	449	744	0	0	0
Interest Income
124	175	257	293	280	245	179	153	137	102	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inducement Expense for Exercise of Warrants
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on Extinguishment of Debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in Fair Value of Warrant Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-1,049	-343	-483	1,040	-433	-120	645	-38	926	676	-1,353	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-
Gain on Sale of Asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Change in Fair Value of Warrant Derivative Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	348	279	299	-79	-155	31	455	-19	46	0	0	0	-	0	-	-	-	-	-	-	-	0	0	-	-	-	-
Gain on Sale of Asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-
Change in Fair Value of Derivative Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	919	908	-249	-111	-122	0	0	0	-	-	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,985	3,015	2,270	406	-1,390	0	0	0	-	-	-	-	-	-	-	-
Change in Fair Value of Warrants Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-
Change in Fair Value of Derivative Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Total Other Income (Expense), net
-13	52	163	190	149	87	-4	-1,013	-1,037	-1,089	-1,154	-250	1,520	1,192	481	709	-1,120	278	152	-190	-207	-1,052	-4,696	-3,588	-3,760	-4,535	-1,216	-2,148	-3,847	-3,236	-2,013	-2,004	-30	0	0	0	-	-	-	-
Net (Loss)
-30,692	-29,306	-36,433	-38,308	-40,275	-39,006	-34,221	-32,115	-27,384	-25,538	-18,183	-18,058	-18,801	-19,437	-22,404	-18,908	-16,838	-13,571	-14,245	-13,221	-12,458	-10,868	-12,087	-9,994	-8,155	-8,240	-4,685	-5,510	-7,194	-6,763	-5,781	-6,401	-4,915	-6,802	0	0	-	0	-	-
Deemed Dividend on Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (Loss) Applicable to Common Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Basic and Diluted (Loss) Per Share
Basic and Diluted (Loss) Per Share (in dollars per share)
-0.15	-0.08	-0.12	-0.16	-0.19	-0.27	-0.21	-0.29	-0.23	-0.24	-0.21	-0.19	-0.26	0.07	-0.41	-0.37	-0.48	-	-	-	-	-	-	-	-	-0.82	0.00	-0.17	-	-0.34	-0.01	-0.03	-0.01	-0.01	-0.02	-0.02	0.02	-0.04	-0.05	-0.04
Basic and Diluted Weighted Average Shares Outstanding (in shares)
66,499	61,921	56,283	47,539	47,311	47,477	42,085	33,389	33,389	33,549	31,509	26,221	22,118	21,579	19,606	15,373	13,444	-	-	-	-	-	-	-	-	6,741	6,169	6,144	-	5,810	98,293	97,206	94,021	91,885	89,698	82,305	123,721	70,005	31,614	29,804
Basic (Loss) Per Share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.28	-0.23	-0.27	-0.24	-0.42	-0.20	-0.27	-0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic Weighted Average Shares Outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,438	13,420	13,415	12,828	10,564	10,514	10,500	10,384	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (Loss) Per Share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.20	-0.24	-0.27	-0.32	-0.42	-0.20	-0.27	-0.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted Weighted Average Shares Outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,740	13,504	13,415	13,086	10,564	10,514	10,500	10,447	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-